Post-acute electrical stimulation treatment of adverse cerebrovascular events
A method for treatment is provided, including identifying that a subject has suffered from an adverse cerebrovascular event, excluding Alzheimer's disease and Parkinson's disease. Responsively to the identifying, beginning at least nine hours after the event, electrical stimulation is applied to a site of the subject selected from the group consisting of: a sphenopalatine ganglion (SPG), a greater palatine nerve, a lesser palatine nerve, a sphenopalatine nerve, a communicating branch between a maxillary nerve and an SPG, an otic ganglion, an afferent fiber going into the otic ganglion, an efferent fiber going out of the otic ganglion, an infraorbital nerve, a vidian nerve, a greater superficial petrosal nerve, and a lesser deep petrosal nerve. The stimulation is configured to excite nervous tissue of the site at a strength sufficient to induce at least an increase in cerebral blood flow (CBF) and/or a release of one or more neuroprotective substances.
1. A method for treatment, comprising:
identifying that a subject has suffered from an adverse cerebrovascular event, excluding Alzheimer's disease and Parkinson's disease;
responsively to the identifying, applying, beginning at least three hours after the event, electrical stimulation to a site of the subject selected from the group consisting of: a sphenopalatine ganglion (SPG), a greater palatine nerve, a lesser palatine nerve, a sphenopalatine nerve, a communicating branch between a maxillary nerve and an SPG, an otic ganglion, an afferent fiber going into the otic ganglion, an efferent fiber going out of the otic ganglion, an infraorbital nerve, a vidian nerve, a greater superficial petrosal nerve, and a lesser deep petrosal nerve; and
configuring the stimulation to excite nervous tissue of the site at a strength (a) sufficient to induce at least one neuroprotective occurrence selected from the group consisting of: an increase in cerebral blood flow (CBF) of the subject, and a release of one or more neuroprotective substances, and (b) insufficient to induce a substantial increase in permeability of a blood-brain barrier (BBB) of the subject.
2. The method according to claim 1 , wherein applying the stimulation comprises applying the stimulation beginning at least six hours after the event.
3. The apparatus according to claim 2 , wherein applying the stimulation comprises applying the stimulation beginning at least nine hours after the event.
4. The method according to claim 3 , wherein applying the stimulation comprises applying the stimulation beginning at least 12 hours after the event.
5. The method according to claim 4 , wherein applying the stimulation comprises applying the stimulation beginning at least 24 hours after the event.
6. The method according to claim 1 , wherein the event includes a stroke, and wherein applying the stimulation comprises applying the stimulation beginning at least three hours after the stroke.
7. The method according to claim 1 , wherein applying the stimulation comprises applying the stimulation intermittently.
8. The apparatus according to claim 1 , wherein the event includes an aneurysm, and wherein applying the stimulation comprises applying the stimulation beginning at least three hours after the aneurysm.
9. The method according to claim 1 , wherein the site includes the SPG, and wherein applying the stimulation comprises applying the stimulation to the SPG.
10. The method according to claim 9 , wherein applying the stimulation comprises:
placing an elongated support element within a greater palatine canal of the subject, sized to extend from a palate of the subject to the SPG, and having a distal end; and
applying the stimulation from a vicinity of the distal end of the support element.